Rachel S Kamgaing, Yagai Bouba, Samuel M Sosso, Jeremiah E Gabisa, Aubin Nanfack, Joseph Fokam, Laure Ngono, Nadine Fainguem, Michel C T Tommo, Krystel N Zam, Junie F Yimga, Désiré K Takou, Alexis Ndjolo
{"title":"低收入和中等收入国家艾滋病毒检测系统面临的挑战。","authors":"Rachel S Kamgaing, Yagai Bouba, Samuel M Sosso, Jeremiah E Gabisa, Aubin Nanfack, Joseph Fokam, Laure Ngono, Nadine Fainguem, Michel C T Tommo, Krystel N Zam, Junie F Yimga, Désiré K Takou, Alexis Ndjolo","doi":"10.4102/ajlm.v12i1.1974","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Determining the HIV status of some individuals remains challenging due to multidimensional factors such as flaws in diagnostic systems, technological challenges, and viral diversity. This report pinpoints challenges faced by the HIV testing system in Cameroon.</p><p><strong>Case presentation: </strong>A 53-year-old male received a positive HIV result by a rapid testing algorithm in July 2016. Not convinced of his HIV status, he requested additional tests. In February 2017, he received a positive result using ImmunoComb<sup>®</sup> II HIV 1 & 2 BiSpot and Roche cobas electrochemiluminescence assays. A sample sent to France in April 2017 was positive on the Bio-Rad GenScreen™ HIV 1/2, but serotyping was indeterminate, and viral load was < 20 copies/mL. The Roche electrochemiluminescence immunoassay and INNO-LIA HIV I/II Score were negative for samples collected in 2018. A sample collected in July 2019 and tested with VIDAS<sup>®</sup> HIV Duo Ultra enzyme-linked fluorescent assay and Geenius™ HIV 1/2 Confirmatory Assay was positive, but negative with Western blot; CD4 count was 1380 cells/mm<sup>3</sup> and HIV proviral DNA tested in France was 'target-not-detected'. Some rapid tests were still positive in 2020 and 2021. Serotyping remained indeterminate, and viral load was 'target-not-detected'. There were no self-reported exposure to HIV risk factors, and his wife was HIV-seronegative.</p><p><strong>Management and outcome: </strong>Given that the patient remained asymptomatic with no evidence of viral replication, no antiretroviral therapy was initiated.</p><p><strong>Conclusion: </strong>This case highlights the struggles faced by some individuals in confirming their HIV status and the need to update existing technologies and develop an algorithm for managing exceptional cases.</p>","PeriodicalId":45412,"journal":{"name":"African Journal of Laboratory Medicine","volume":"12 1","pages":"1974"},"PeriodicalIF":1.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900299/pdf/","citationCount":"0","resultStr":"{\"title\":\"Challenges faced by the HIV testing system in low- and middle-income countries.\",\"authors\":\"Rachel S Kamgaing, Yagai Bouba, Samuel M Sosso, Jeremiah E Gabisa, Aubin Nanfack, Joseph Fokam, Laure Ngono, Nadine Fainguem, Michel C T Tommo, Krystel N Zam, Junie F Yimga, Désiré K Takou, Alexis Ndjolo\",\"doi\":\"10.4102/ajlm.v12i1.1974\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Determining the HIV status of some individuals remains challenging due to multidimensional factors such as flaws in diagnostic systems, technological challenges, and viral diversity. This report pinpoints challenges faced by the HIV testing system in Cameroon.</p><p><strong>Case presentation: </strong>A 53-year-old male received a positive HIV result by a rapid testing algorithm in July 2016. Not convinced of his HIV status, he requested additional tests. In February 2017, he received a positive result using ImmunoComb<sup>®</sup> II HIV 1 & 2 BiSpot and Roche cobas electrochemiluminescence assays. A sample sent to France in April 2017 was positive on the Bio-Rad GenScreen™ HIV 1/2, but serotyping was indeterminate, and viral load was < 20 copies/mL. The Roche electrochemiluminescence immunoassay and INNO-LIA HIV I/II Score were negative for samples collected in 2018. A sample collected in July 2019 and tested with VIDAS<sup>®</sup> HIV Duo Ultra enzyme-linked fluorescent assay and Geenius™ HIV 1/2 Confirmatory Assay was positive, but negative with Western blot; CD4 count was 1380 cells/mm<sup>3</sup> and HIV proviral DNA tested in France was 'target-not-detected'. Some rapid tests were still positive in 2020 and 2021. Serotyping remained indeterminate, and viral load was 'target-not-detected'. There were no self-reported exposure to HIV risk factors, and his wife was HIV-seronegative.</p><p><strong>Management and outcome: </strong>Given that the patient remained asymptomatic with no evidence of viral replication, no antiretroviral therapy was initiated.</p><p><strong>Conclusion: </strong>This case highlights the struggles faced by some individuals in confirming their HIV status and the need to update existing technologies and develop an algorithm for managing exceptional cases.</p>\",\"PeriodicalId\":45412,\"journal\":{\"name\":\"African Journal of Laboratory Medicine\",\"volume\":\"12 1\",\"pages\":\"1974\"},\"PeriodicalIF\":1.0000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900299/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"African Journal of Laboratory Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4102/ajlm.v12i1.1974\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"African Journal of Laboratory Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4102/ajlm.v12i1.1974","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
摘要
由于诊断系统的缺陷、技术挑战和病毒多样性等多方面因素,确定某些个体的HIV状态仍然具有挑战性。这份报告指出了喀麦隆艾滋病毒检测系统面临的挑战。病例介绍:2016年7月,一名53岁男性通过快速检测算法检测出HIV阳性。由于不确信自己感染了艾滋病毒,他要求进行进一步检查。2017年2月,他使用ImmunoComb®II HIV 1 & 2 BiSpot和Roche cobas电化学发光检测获得阳性结果。2017年4月寄往法国的一份样本Bio-Rad GenScreen™HIV 1/2阳性,但血清分型不确定,病毒载量< 20拷贝/mL。2018年采集的样本罗氏电化学发光免疫测定和INNO-LIA HIV I/II评分均为阴性。2019年7月采集的样本,用VIDAS®HIV Duo Ultra酶联荧光法和genenius™HIV 1/2验证法检测呈阳性,但用Western blot检测呈阴性;CD4细胞计数为1380个细胞/mm3,在法国测试的HIV前病毒DNA是“未检测到目标”。一些快速检测在2020年和2021年仍呈阳性。血清分型仍然不确定,病毒载量“未检测到目标”。没有自我报告暴露于艾滋病毒危险因素,他的妻子是艾滋病毒血清阴性。处理和结果:鉴于患者没有症状,没有病毒复制的证据,没有开始抗逆转录病毒治疗。结论:这个案例突出了一些人在确认自己的艾滋病毒状态时所面临的困难,以及更新现有技术和开发管理特殊病例的算法的必要性。
Challenges faced by the HIV testing system in low- and middle-income countries.
Introduction: Determining the HIV status of some individuals remains challenging due to multidimensional factors such as flaws in diagnostic systems, technological challenges, and viral diversity. This report pinpoints challenges faced by the HIV testing system in Cameroon.
Case presentation: A 53-year-old male received a positive HIV result by a rapid testing algorithm in July 2016. Not convinced of his HIV status, he requested additional tests. In February 2017, he received a positive result using ImmunoComb® II HIV 1 & 2 BiSpot and Roche cobas electrochemiluminescence assays. A sample sent to France in April 2017 was positive on the Bio-Rad GenScreen™ HIV 1/2, but serotyping was indeterminate, and viral load was < 20 copies/mL. The Roche electrochemiluminescence immunoassay and INNO-LIA HIV I/II Score were negative for samples collected in 2018. A sample collected in July 2019 and tested with VIDAS® HIV Duo Ultra enzyme-linked fluorescent assay and Geenius™ HIV 1/2 Confirmatory Assay was positive, but negative with Western blot; CD4 count was 1380 cells/mm3 and HIV proviral DNA tested in France was 'target-not-detected'. Some rapid tests were still positive in 2020 and 2021. Serotyping remained indeterminate, and viral load was 'target-not-detected'. There were no self-reported exposure to HIV risk factors, and his wife was HIV-seronegative.
Management and outcome: Given that the patient remained asymptomatic with no evidence of viral replication, no antiretroviral therapy was initiated.
Conclusion: This case highlights the struggles faced by some individuals in confirming their HIV status and the need to update existing technologies and develop an algorithm for managing exceptional cases.
期刊介绍:
The African Journal of Laboratory Medicine, the official journal of ASLM, focuses on the role of the laboratory and its professionals in the clinical and public healthcare sectors,and is specifically based on an African frame of reference. Emphasis is on all aspects that promote and contribute to the laboratory medicine practices of Africa. This includes, amongst others: laboratories, biomedical scientists and clinicians, medical community, public health officials and policy makers, laboratory systems and policies (translation of laboratory knowledge, practices and technologies in clinical care), interfaces of laboratory with medical science, laboratory-based epidemiology, laboratory investigations, evidence-based effectiveness in real world (actual) settings.